Breast Cancer Clinical Trial
Official title:
Pilot Test of the Effect of Cancer Nurse Navigators on Patient Outcomes
Verified date | November 2015 |
Source | University of Wisconsin, Madison |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
There is widespread anecdotal evidence that Cancer Nurse Navigators (CNNs) are highly valued
by cancer patients, but no studies have evaluated the effects of CNNs on important
patient-reported outcomes or indicators of quality of care. This study has two aims:
1. To assess the feasibility of studying the impact of Aurora CNN Program.
2. To pilot test the effects of CNN services on patient-reported outcomes and indicators of
quality of care.
Status | Terminated |
Enrollment | 16 |
Est. completion date | May 2012 |
Est. primary completion date | May 2012 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Adult (18 years of age or older) 2. Treated at Aurora St. Luke's or West Allis Medical Center 3. New or recurrent dx of lung, prostate, colorectal or breast cancer - Exclusion Criteria: 1. Previously received CNN services at an Aurora treatment facility 2. Unable to read/write in English 3. Living in a nursing home/long term care facility 4. Not capable of completing study questionnaires - |
Country | Name | City | State |
---|---|---|---|
United States | Aurora St. Luke's Hospital | Milwaukee | Wisconsin |
United States | Aurora West Allis | West Allis | Wisconsin |
Lead Sponsor | Collaborator |
---|---|
University of Wisconsin, Madison | Aurora Health Care |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Satisfaction with Care | Change from baseline, to 3 months to 6 months | ||
Secondary | ED/Urgent care visits | Baseline, 3 months, 6 months | ||
Secondary | Quality of Life | The Functional Assessment Cancer Therapy - General (FACT-G) assesses quality of life. | Baseline, 3 months, 6 months | |
Secondary | Distressed mood | The National Comprehensive Cancer Network Distress Thermometer assesses level of distress. | Baseline, 3 months, 6 months | |
Secondary | Symptom Distress | The Memorial Symptom Assessment Scale measures 32 common physical and psychological cancer-related symptoms. | Baseline, 3 months, 6 months | |
Secondary | The Inventory of Recent Life Experiences for Cancer Patients | This instrument measures 30 cancer-related irritants (hassles) commonly experienced by persons with cancer. | Baseline, 3 months, 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |